![]() |


![]() |
Create Name: | |
Description: |
![]() |
Save what matters to you |
{{ loginError }} |
Sign in with your RGD account |
Create New Account | Recover Password |
Analyze GeneStrainQTL List |
![]() Gene Annotator (Functional Annotation) unavailable |
![]() Gene Annotator (Annotation Distribution) unavailable |
![]() Variant Visualizer (Genomic Variants) unavailble Variant Visualizer (Genomic Variants) unavailable |
Gene Annotator (Functional Annotation) |
Gene Annotator (Annotation Distribution) |
Variant Visualizer (Genomic Variants) |
![]() InterViewer (Protein-Protein Interactions) unavailable |
![]() Gviewer (Genome Viewer) unavailable |
![]() Variant Visualizer (Damaging Variants) unavailble Variant Visualizer (Damaging Variants) unavailable |
InterViewer (Protein-Protein Interactions) |
GViewer (Genome Viewer) |
Variant Visualizer (Damaging Variants) |
![]() Gene Annotator (Annotation Comparison) unavailable |
![]() OLGA (Gene List Generator) unavailable |
![]() |
Gene Annotator (Annotation Comparison) |
OLGA (Gene List Generator) |
Excel (Download) |
![]() MOET (Multi-Ontology Enrichement) unavailable |
![]() GOLF (Gene-Ortholog Location Finder) unavailable |
|
MOET (Multi-Ontology Enrichement) |
GOLF (Gene-Ortholog Location Finder) |
![]() Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | ISO | RGD:1308086 | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of POLR3E mRNA] | CTD | PMID:31150632 | 1,1-dichloroethene | decreases expression | ISO | RGD:1317655 | 6480464 | vinylidene chloride results in decreased expression of POLR3E mRNA | CTD | PMID:26682919 | 17beta-hydroxy-5alpha-androstan-3-one | increases expression | EXP | | 6480464 | Dihydrotestosterone results in increased expression of POLR3E mRNA | CTD | PMID:29581250 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of POLR3E mRNA | CTD | PMID:21632981 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1317655 | 6480464 | Tetrachlorodibenzodioxin affects the expression of POLR3E mRNA | CTD | PMID:21570461 | 2,4-dinitrotoluene | affects expression | ISO | RGD:1308086 | 6480464 | 2, 4-dinitrotoluene affects the expression of POLR3E mRNA | CTD | PMID:21346803 | 2,6-dinitrotoluene | affects expression | ISO | RGD:1308086 | 6480464 | 2, 6-dinitrotoluene affects the expression of POLR3E mRNA | CTD | PMID:21346803 | 4-hydroxyphenyl retinamide | increases expression | ISO | RGD:1317655 | 6480464 | Fenretinide results in increased expression of POLR3E mRNA | CTD | PMID:28973697 | 5-aza-2'-deoxycytidine | decreases expression | EXP | | 6480464 | Decitabine results in decreased expression of POLR3E mRNA | CTD | PMID:19194470 | amphetamine | decreases expression | ISO | RGD:1308086 | 6480464 | Amphetamine results in decreased expression of POLR3E mRNA | CTD | PMID:30779732 | Aroclor 1254 | decreases expression | ISO | RGD:1317655 | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased expression of POLR3E mRNA | CTD | PMID:23650126 | benzo[a]pyrene | increases expression | ISO | RGD:1317655 | 6480464 | Benzo(a)pyrene results in increased expression of POLR3E mRNA | CTD | PMID:22228805 | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of POLR3E intron | CTD | PMID:30157460 | benzo[a]pyrene diol epoxide I | decreases expression | EXP | | 6480464 | 7 more ... | CTD | PMID:19150397, PMID:26238291 | benzo[e]pyrene | increases methylation | EXP | | 6480464 | benzo(e)pyrene results in increased methylation of POLR3E intron | CTD | PMID:30157460 | bisphenol A | increases expression | ISO | RGD:1308086 | 6480464 | bisphenol A results in increased expression of POLR3E mRNA | CTD | PMID:25181051 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of POLR3E mRNA | CTD | PMID:30903817 | bisphenol A | increases methylation | ISO | RGD:1308086 | 6480464 | bisphenol A results in increased methylation of POLR3E gene | CTD | PMID:28505145 | bortezomib | increases expression | EXP | | 6480464 | Bortezomib results in increased expression of POLR3E mRNA | CTD | PMID:20977926 | cadmium dichloride | decreases expression | ISO | RGD:1317655 | 6480464 | Cadmium Chloride results in decreased expression of POLR3E mRNA | CTD | PMID:20883709 | carbon nanotube | increases expression | ISO | RGD:1317655 | 6480464 | Nanotubes, Carbon analog results in increased expression of POLR3E mRNA | CTD | PMID:25620056 | cisplatin | multiple interactions | EXP | | 6480464 | [Cisplatin co-treated with panobinostat] affects the expression of POLR3E mRNA | CTD | PMID:21791302 | cobalt atom | multiple interactions | ISO | RGD:1308086 | 6480464 | [Tungsten co-treated with Nickel co-treated with Cobalt] results in increased expression of POLR3E mRNA | CTD | PMID:24619124 | cobalt dichloride | increases expression | ISO | RGD:1308086 | 6480464 | cobaltous chloride results in increased expression of POLR3E mRNA | CTD | PMID:24619124 | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of POLR3E mRNA | CTD | PMID:25562108 | cylindrospermopsin | increases expression | EXP | | 6480464 | cylindrospermopsin results in increased expression of POLR3E mRNA | CTD | PMID:24921660 | endosulfan | increases expression | ISO | RGD:1308086 | 6480464 | Endosulfan results in increased expression of POLR3E mRNA | CTD | PMID:29391264 | ethyl methanesulfonate | decreases expression | EXP | | 6480464 | Ethyl Methanesulfonate results in decreased expression of POLR3E mRNA | CTD | PMID:23649840 | formaldehyde | decreases expression | EXP | | 6480464 | Formaldehyde results in decreased expression of POLR3E mRNA | CTD | PMID:23649840 | iron atom | multiple interactions | ISO | RGD:1308086 | 6480464 | [Tungsten co-treated with Nickel co-treated with Iron] results in increased expression of POLR3E mRNA | CTD | PMID:24619124 | iron(0) | multiple interactions | ISO | RGD:1308086 | 6480464 | [Tungsten co-treated with Nickel co-treated with Iron] results in increased expression of POLR3E mRNA | CTD | PMID:24619124 | menadione | affects expression | EXP | | 6480464 | Vitamin K 3 affects the expression of POLR3E mRNA | CTD | PMID:20044591 | methamphetamine | decreases expression | ISO | RGD:1308086 | 6480464 | Methamphetamine results in decreased expression of POLR3E mRNA | CTD | PMID:19564919 | methapyrilene | increases methylation | EXP | | 6480464 | Methapyrilene results in increased methylation of POLR3E intron | CTD | PMID:30157460 | methotrexate | decreases expression | EXP | | 6480464 | Methotrexate results in decreased expression of POLR3E mRNA | CTD | PMID:24449571 | methyl methanesulfonate | decreases expression | EXP | | 6480464 | Methyl Methanesulfonate results in decreased expression of POLR3E mRNA | CTD | PMID:23649840 | nickel atom | multiple interactions | ISO | RGD:1308086 | 6480464 | [Tungsten co-treated with Nickel co-treated with Cobalt] results in increased expression of POLR3E mRNA, [Tungsten co-treated with Nickel co-treated with Iron] results in increased expression of POLR3E mRNA | CTD | PMID:24619124 | panobinostat | multiple interactions | EXP | | 6480464 | [Cisplatin co-treated with panobinostat] affects the expression of POLR3E mRNA | CTD | PMID:21791302 | paracetamol | affects expression | ISO | RGD:1317655 | 6480464 | Acetaminophen affects the expression of POLR3E mRNA | CTD | PMID:17562736 | sodium arsenite | decreases expression | ISO | RGD:1317655 | 6480464 | sodium arsenite results in decreased expression of POLR3E mRNA | CTD | PMID:20883709 | tetrachloromethane | increases expression | ISO | RGD:1308086 | 6480464 | Carbon Tetrachloride results in increased expression of POLR3E mRNA | CTD | PMID:31150632 | tetrachloromethane | multiple interactions | ISO | RGD:1308086 | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of POLR3E mRNA] | CTD | PMID:31150632 | thapsigargin | decreases expression | ISO | RGD:1317655 | 6480464 | Thapsigargin results in decreased expression of POLR3E protein | CTD | PMID:24648495 | titanium dioxide | decreases expression | ISO | RGD:1317655 | 6480464 | titanium dioxide results in decreased expression of POLR3E mRNA | CTD | PMID:29264374 | trichostatin A | affects expression | EXP | | 6480464 | trichostatin A affects the expression of POLR3E mRNA | CTD | PMID:28542535 | tungsten | multiple interactions | ISO | RGD:1308086 | 6480464 | [Tungsten co-treated with Nickel co-treated with Cobalt] results in increased expression of POLR3E mRNA, [Tungsten co-treated with Nickel co-treated with Iron] results in increased expression of POLR3E mRNA | CTD | PMID:24619124 | valproic acid | decreases methylation | EXP | | 6480464 | Valproic Acid results in decreased methylation of POLR3E gene | CTD | PMID:29154799 | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of POLR3E mRNA | CTD | PMID:25979313 | valproic acid | affects expression | ISO | RGD:1317655 | 6480464 | Valproic Acid affects the expression of POLR3E mRNA | CTD | PMID:17292431 | vancomycin | increases expression | ISO | RGD:1317655 | 6480464 | Vancomycin results in increased expression of POLR3E mRNA | CTD | PMID:18930951 | vinclozolin | decreases expression | ISO | RGD:1308086 | 6480464 | vinclozolin results in decreased expression of POLR3E mRNA | CTD | PMID:23034163 | |
|
|
|
|
|
|
|
|
|
|
|
1. | Dumay-Odelot H, etal., Cell Cycle. 2010 Sep 15;9(18):3687-99. Epub 2010 Sep 1. |
2. | GOA_HUMAN data from the GO Consortium |
3. | Hu P, etal., Mol Cell Biol. 2002 Nov;22(22):8044-55. |
4. | Pipeline to import KEGG annotations from KEGG into RGD |
5. | RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations |
6. | RGD automated import pipeline for gene-chemical interactions |
PubMed | 1403646 8125298 10521666 10819331 12477932 14702039 15489334 16344560 17643375 18029348 19214185 19615732 21873635 24107381 26186194 26344197 26496610 27780869 28514442 29117863 29728610 |
POLR3E (Homo sapiens - human) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Polr3e (Mus musculus - house mouse) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Polr3e (Rattus norvegicus - Norway rat) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Polr3e (Chinchilla lanigera - long-tailed chinchilla) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
POLR3E (Pan paniscus - bonobo/pygmy chimpanzee) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
POLR3E (Canis lupus familiaris - dog) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Polr3e (Ictidomys tridecemlineatus - thirteen-lined ground squirrel) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
POLR3E (Sus scrofa - pig) |
|
STS-W72446 |
|
|||||||||||||||||||||||||||||||||||||||||||||
RH80971 |
|
|||||||||||||||||||||||||||||||||||||||||||||
POLR3E_8065 |
|
|||||||||||||||||||||||||||||||||||||||||||||
D16S2974 |
|
The detailed report is available here: | ![]() | Full Report | ![]() | CSV | ![]() | TAB | ![]() | Printer |
miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/). For more information about miRGate, see PMID:25858286 or access the full paper here. |
RefSeq Transcripts | NM_001258033 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles |
NM_001258034 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
NM_001258035 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
NM_001258036 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
NM_018119 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
NR_047581 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
XM_011545892 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
XM_011545893 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
XM_017023443 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
GenBank Nucleotide | AA282721 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles |
AB040885 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AC009034 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AC092338 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AC241556 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AK001371 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AK023160 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AK023231 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AK026645 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AK130661 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AK222671 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AK222789 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AK293300 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AK296813 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AK300735 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AL048627 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AW205673 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AX876608 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AY092085 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
BC000285 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
CH471249 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
DB047155 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles |
RefSeq Acc Id: | NM_001258033 ⟹ NP_001244962 | ||||||||||||||||||||||||
RefSeq Status: | VALIDATED | ||||||||||||||||||||||||
Type: | CODING | ||||||||||||||||||||||||
Position: |
|
||||||||||||||||||||||||
Sequence: |
AAGAGGAAACGCTGGGGCCGGCCCGCTCCCCCCCACGTGTCCGCCGGAGTTTCTCCACCAGCAAhide sequence |
RefSeq Acc Id: | NM_001258034 ⟹ NP_001244963 | ||||||||||||||||||||||||
RefSeq Status: | VALIDATED | ||||||||||||||||||||||||
Type: | CODING | ||||||||||||||||||||||||
Position: |
|
||||||||||||||||||||||||
Sequence: |
AAGAGGAAACGCTGGGGCCGGCCCGCTCCCCCCCACGTGTCCGCCGGAGTTTCTCCACCAGCAAhide sequence |
RefSeq Acc Id: | NM_001258035 ⟹ NP_001244964 | ||||||||||||||||||||||||
RefSeq Status: | VALIDATED | ||||||||||||||||||||||||
Type: | CODING | ||||||||||||||||||||||||
Position: |
|
||||||||||||||||||||||||
Sequence: |
AAGAGGAAACGCTGGGGCCGGCCCGCTCCCCCCCACGTGTCCGCCGGAGTTTCTCCACCAGCAAhide sequence |
RefSeq Acc Id: | NM_001258036 ⟹ NP_001244965 | ||||||||||||||||||||||||
RefSeq Status: | VALIDATED | ||||||||||||||||||||||||
Type: | CODING | ||||||||||||||||||||||||
Position: |
|
||||||||||||||||||||||||
Sequence: |
AAGAGGAAACGCTGGGGCCGGCCCGCTCCCCCCCACGTGTCCGCCGGAGTTTCTCCACCAGCAAhide sequence |
RefSeq Acc Id: | NM_018119 ⟹ NP_060589 | ||||||||||||||||||||||||||||||||||
RefSeq Status: | VALIDATED | ||||||||||||||||||||||||||||||||||
Type: | CODING | ||||||||||||||||||||||||||||||||||
Position: |
|
||||||||||||||||||||||||||||||||||
Sequence: |
AAGAGGAAACGCTGGGGCCGGCCCGCTCCCCCCCACGTGTCCGCCGGAGTTTCTCCACCAGCAAhide sequence |
RefSeq Acc Id: | NR_047581 | ||||||||||||||||||||||||
RefSeq Status: | VALIDATED | ||||||||||||||||||||||||
Type: | NON-CODING | ||||||||||||||||||||||||
Position: |
|
||||||||||||||||||||||||
Sequence: |
AAGAGGAAACGCTGGGGCCGGCCCGCTCCCCCCCACGTGTCCGCCGGAGTTTCTCCACCAGCAAhide sequence |
RefSeq Acc Id: | XM_011545892 ⟹ XP_011544194 | |||||||||
RefSeq Status: | ||||||||||
Type: | CODING | |||||||||
Position: |
|
|||||||||
Sequence: |
ACGTGTCCGCCGGAGTTTCTCCACCAGCAACATGGCCGCCGCCTGAGAGGAGAGCCGGGCCGCChide sequence |
RefSeq Acc Id: | XM_011545893 ⟹ XP_011544195 | |||||||||
RefSeq Status: | ||||||||||
Type: | CODING | |||||||||
Position: |
|
|||||||||
Sequence: |
ACGTGTCCGCCGGAGTTTCTCCACCAGCAACATGGCCGCCGCCTGAGAGGAGAGCCGGGCCGCChide sequence |
RefSeq Acc Id: | XM_017023443 ⟹ XP_016878932 | |||||||||
RefSeq Status: | ||||||||||
Type: | CODING | |||||||||
Position: |
|
|||||||||
Sequence: |
ACGTGTCCGCCGGAGTTTCTCCACCAGCAACATGGCCGCCGCCTGAGAGGAGAGCCGGGCCGCChide sequence |
Protein RefSeqs | NP_001244962 | (Get FASTA) | NCBI Sequence Viewer |
NP_001244963 | (Get FASTA) | NCBI Sequence Viewer | |
NP_001244964 | (Get FASTA) | NCBI Sequence Viewer | |
NP_001244965 | (Get FASTA) | NCBI Sequence Viewer | |
NP_060589 | (Get FASTA) | NCBI Sequence Viewer | |
XP_011544194 | (Get FASTA) | NCBI Sequence Viewer | |
XP_011544195 | (Get FASTA) | NCBI Sequence Viewer | |
XP_016878932 | (Get FASTA) | NCBI Sequence Viewer | |
GenBank Protein | AAH00285 | (Get FASTA) | NCBI Sequence Viewer |
AAM18215 | (Get FASTA) | NCBI Sequence Viewer | |
BAA91655 | (Get FASTA) | NCBI Sequence Viewer | |
BAA95976 | (Get FASTA) | NCBI Sequence Viewer | |
BAB14437 | (Get FASTA) | NCBI Sequence Viewer | |
BAB14481 | (Get FASTA) | NCBI Sequence Viewer | |
BAD96509 | (Get FASTA) | NCBI Sequence Viewer | |
BAG56821 | (Get FASTA) | NCBI Sequence Viewer | |
BAG59386 | (Get FASTA) | NCBI Sequence Viewer | |
BAG62408 | (Get FASTA) | NCBI Sequence Viewer | |
CAE89351 | (Get FASTA) | NCBI Sequence Viewer | |
EAW50605 | (Get FASTA) | NCBI Sequence Viewer | |
EAW50606 | (Get FASTA) | NCBI Sequence Viewer | |
EAW50607 | (Get FASTA) | NCBI Sequence Viewer | |
EAW50608 | (Get FASTA) | NCBI Sequence Viewer | |
Q9NVU0 | (Get FASTA) | NCBI Sequence Viewer |
RefSeq Acc Id: | NP_060589 ⟸ NM_018119 |
- Peptide Label: | isoform 1 |
- UniProtKB: | Q9NVU0 (UniProtKB/Swiss-Prot) |
- Sequence: |
MANEEDDPVVQEIDVYLAKSLAEKLYLFQYPVRPASMTYDDIPHLSAKIKPKQQKVELEMAIDThide sequence |
RefSeq Acc Id: | NP_001244962 ⟸ NM_001258033 |
- Peptide Label: | isoform 2 |
- UniProtKB: | Q9NVU0 (UniProtKB/Swiss-Prot) |
- Sequence: |
MANEEDDPVVQEIDVYLAKSLAEKLYLFQYPVRPASMTYDDIPHLSAKIKPKQQKVELEMAIDThide sequence |
RefSeq Acc Id: | NP_001244965 ⟸ NM_001258036 |
- Peptide Label: | isoform 5 |
- UniProtKB: | Q9NVU0 (UniProtKB/Swiss-Prot) |
- Sequence: |
MANEEDDPVVQEIDVYLAKSLAEKLYLFQYPVRPASMTYDDIPHLSAKIKPKQQKVELEMAIDThide sequence |
RefSeq Acc Id: | NP_001244963 ⟸ NM_001258034 |
- Peptide Label: | isoform 4 |
- UniProtKB: | Q9NVU0 (UniProtKB/Swiss-Prot) |
- Sequence: |
MANEEDDPVVQEIKPKQQKVELEMAIDTLNPNYCRSKGEQIALNVDGACADETSTYSSKLMDKQhide sequence |
RefSeq Acc Id: | NP_001244964 ⟸ NM_001258035 |
- Peptide Label: | isoform 3 |
- UniProtKB: | Q9NVU0 (UniProtKB/Swiss-Prot), A0A0C4DH01 (UniProtKB/TrEMBL) |
- Sequence: |
MTYDDIPHLSAKIKPKQQKVELEMAIDTLNPNYCRSKGEQIALNVDGACADETSTYSSKLMDKQhide sequence |
RefSeq Acc Id: | XP_011544194 ⟸ XM_011545892 |
- Peptide Label: | isoform X1 |
- Sequence: |
MANEEDDPVVQEIDVYLAKSLAEKLYLFQYPVRPASMTYDDIPHLSAKIKPKQQKVELEMAIDThide sequence |
RefSeq Acc Id: | XP_011544195 ⟸ XM_011545893 |
- Peptide Label: | isoform X2 |
- Sequence: |
MANEEDDPVVQEIDVYLAKSLAEKLYLFQYPVRPASMTYDDIPHLSAKIKPKQQKVELEMAIDThide sequence |
RefSeq Acc Id: | XP_016878932 ⟸ XM_017023443 |
- Peptide Label: | isoform X3 |
- Sequence: |
MPLHSTGELHLTPLHGILQLRPSFSYLDKADAKHREREAANEAGDSSQDEAEDDVKQITVRFSRhide sequence |
RGD ID: | 6793383 | |||||||||
Promoter ID: | HG_KWN:23275 | |||||||||
Type: | CpG-Island | |||||||||
SO ACC ID: | SO:0000170 | |||||||||
Source: | MPROMDB | |||||||||
Tissues & Cell Lines: | CD4+TCell, CD4+TCell_12Hour, CD4+TCell_2Hour, HeLa_S3, Jurkat, K562, Lymphoblastoid, NB4 | |||||||||
Transcripts: | OTTHUMT00000211590, UC002DKJ.1, UC002DKL.1, UC002DKM.1 | |||||||||
Position: |
|
RGD ID: | 6850906 | |||||||||
Promoter ID: | EP73249 | |||||||||
Type: | initiation region | |||||||||
Name: | HS_FLJ10509 | |||||||||
Description: | RNA polymerase III 80 kDa subunit RPC5. | |||||||||
SO ACC ID: | SO:0000170 | |||||||||
Source: | EPD (Eukaryotic Promoter Database, http://epd.vital-it.ch/) | |||||||||
Experiment Methods: | NEDO full length human cDNA sequencing project.; Oligo-capping | |||||||||
Position: |
|
RGD ID: | 7231585 | |||||||||
Promoter ID: | EPDNEW_H21538 | |||||||||
Type: | initiation region | |||||||||
Name: | POLR3E_1 | |||||||||
Description: | RNA polymerase III subunit E | |||||||||
SO ACC ID: | SO:0000170 | |||||||||
Source: | EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/) | |||||||||
Experiment Methods: | Single-end sequencing. | |||||||||
Position: |
|
RGD ID: | 7231587 | |||||||||
Promoter ID: | EPDNEW_H21539 | |||||||||
Type: | single initiation site | |||||||||
Name: | POLR3E_2 | |||||||||
Description: | RNA polymerase III subunit E | |||||||||
SO ACC ID: | SO:0000170 | |||||||||
Source: | EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/) | |||||||||
Experiment Methods: | Single-end sequencing. | |||||||||
Position: |
|
Name | Type | Condition(s) | Position(s) | Clinical significance |
GRCh38/hg38 16p12.2(chr16:21825971-22396751)x1 | copy number loss | Global developmental delay [RCV000050457]|See cases [RCV000050457] | Chr16:21825971..22396751 [GRCh38] Chr16:21837292..22408072 [GRCh37] Chr16:21744793..22315573 [NCBI36] Chr16:16p12.2 |
benign|uncertain significance|conflicting data from submitters |
GRCh38/hg38 16p12.2(chr16:21826171-22358401)x3 | copy number gain | Global developmental delay [RCV000050396]|See cases [RCV000050396] | Chr16:21826171..22358401 [GRCh38] Chr16:21837492..22369722 [GRCh37] Chr16:16p12.2 |
uncertain significance |
GRCh38/hg38 16p12.2(chr16:21826171-22396610)x3 | copy number gain | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000050397]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000050397]|See cases [RCV000050397] | Chr16:21826171..22396610 [GRCh38] Chr16:21837492..22407931 [GRCh37] Chr16:21744993..22315432 [NCBI36] Chr16:16p12.2 |
uncertain significance |
GRCh38/hg38 16p12.2(chr16:21826171-22396610)x1 | copy number loss | Gonadal dysgenesis [RCV000050398]|Global developmental delay [RCV000050399]|Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000050400]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000050400]|See cases [RCV000050398] | Chr16:21826171..22396610 [GRCh38] Chr16:21837492..22407931 [GRCh37] Chr16:21744993..22315432 [NCBI36] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance|conflicting data from submitters |
GRCh38/hg38 16p12.2(chr16:21642883-22396751)x1 | copy number loss | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051266]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051266]|See cases [RCV000051266] | Chr16:21642883..22396751 [GRCh38] Chr16:21654204..22408072 [GRCh37] Chr16:21561705..22315573 [NCBI36] Chr16:16p12.2 |
uncertain significance |
GRCh38/hg38 16p12.2(chr16:21794978-22396610)x1 | copy number loss | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051267]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051267]|See cases [RCV000051267] | Chr16:21794978..22396610 [GRCh38] Chr16:21806299..22407931 [GRCh37] Chr16:21713800..22315432 [NCBI36] Chr16:16p12.2 |
uncertain significance |
GRCh38/hg38 16p12.2(chr16:21826171-22634444)x1 | copy number loss | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051268]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051268]|See cases [RCV000051268] | Chr16:21826171..22634444 [GRCh38] Chr16:21837492..22645765 [GRCh37] Chr16:21744993..22553266 [NCBI36] Chr16:16p12.2 |
uncertain significance |
GRCh38/hg38 16p12.2(chr16:21940058-22396610)x1 | copy number loss | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051269]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051269]|See cases [RCV000051269] | Chr16:21940058..22396610 [GRCh38] Chr16:21951379..22407931 [GRCh37] Chr16:21858880..22315432 [NCBI36] Chr16:16p12.2 |
uncertain significance |
GRCh38/hg38 16p12.2(chr16:21973700-22396610)x1 | copy number loss | Spina bifida occulta [RCV000051287]|See cases [RCV000051287] | Chr16:21973700..22396610 [GRCh38] Chr16:21985021..22407931 [GRCh37] Chr16:21892522..22315432 [NCBI36] Chr16:16p12.2 |
uncertain significance |
GRCh38/hg38 16p13.11-12.1(chr16:14954894-28306843)x3 | copy number gain | Nonsyndromic microcephaly [RCV000051828]|See cases [RCV000051828] | Chr16:14954894..28306843 [GRCh38] Chr16:15048751..28318164 [GRCh37] Chr16:14956252..28225665 [NCBI36] Chr16:16p13.11-12.1 |
pathogenic |
GRCh38/hg38 16p12.2-11.2(chr16:21463739-29249579)x3 | copy number gain | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051829]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051829]|See cases [RCV000051829] | Chr16:21463739..29249579 [GRCh38] Chr16:21475060..29260900 [GRCh37] Chr16:21382561..29168401 [NCBI36] Chr16:16p12.2-11.2 |
pathogenic |
GRCh38/hg38 16p12.2-11.2(chr16:21602183-29314373)x3 | copy number gain | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051842]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051842]|See cases [RCV000051842] | Chr16:21602183..29314373 [GRCh38] Chr16:21613504..29325694 [GRCh37] Chr16:21521005..29233195 [NCBI36] Chr16:16p12.2-11.2 |
pathogenic |
GRCh38/hg38 16p12.2-12.1(chr16:21600992-28323344)x1 | copy number loss | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052519]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052519]|See cases [RCV000052519] | Chr16:21600992..28323344 [GRCh38] Chr16:21612313..28334665 [GRCh37] Chr16:21519814..28242166 [NCBI36] Chr16:16p12.2-12.1 |
pathogenic |
GRCh38/hg38 16p12.2(chr16:21299678-22396751)x3 | copy number gain | Language impairment [RCV000053116]|See cases [RCV000053116] | Chr16:21299678..22396751 [GRCh38] Chr16:21310999..22408072 [GRCh37] Chr16:21218500..22315573 [NCBI36] Chr16:16p12.2 |
uncertain significance |
GRCh38/hg38 16p12.2(chr16:21463739-22634444)x3 | copy number gain | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053117]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053117]|See cases [RCV000053117] | Chr16:21463739..22634444 [GRCh38] Chr16:21475060..22645765 [GRCh37] Chr16:21382561..22553266 [NCBI36] Chr16:16p12.2 |
uncertain significance |
NM_018119.3(POLR3E):c.210C>T (p.Cys70=) | single nucleotide variant | Malignant melanoma [RCV000071036] | Chr16:22308969 [GRCh38] Chr16:22320290 [GRCh37] Chr16:22227791 [NCBI36] Chr16:16p12.2 |
not provided |
GRCh38/hg38 16p13.3-11.2(chr16:4644892-29170820)x3 | copy number gain | See cases [RCV000133809] | Chr16:4644892..29170820 [GRCh38] Chr16:4694893..29182141 [GRCh37] Chr16:4634894..29089642 [NCBI36] Chr16:16p13.3-11.2 |
pathogenic |
GRCh38/hg38 16p12.2(chr16:21826171-22358401)x3 | copy number gain | See cases [RCV000050396] | Chr16:21826171..22358401 [GRCh38] Chr16:21837492..22369722 [GRCh37] Chr16:21744993..22277223 [NCBI36] Chr16:16p12.2 |
uncertain significance |
GRCh38/hg38 16p12.2(chr16:21948629-22396630)x1 | copy number loss | See cases [RCV000134017] | Chr16:21948629..22396630 [GRCh38] Chr16:21959950..22407951 [GRCh37] Chr16:21867451..22315452 [NCBI36] Chr16:16p12.2 |
uncertain significance|conflicting data from submitters |
GRCh38/hg38 16p12.2(chr16:22055774-22634444)x3 | copy number gain | See cases [RCV000135757] | Chr16:22055774..22634444 [GRCh38] Chr16:22067095..22645765 [GRCh37] Chr16:21974596..22553266 [NCBI36] Chr16:16p12.2 |
uncertain significance |
GRCh38/hg38 16p12.2(chr16:21826171-22358401)x1 | copy number loss | See cases [RCV000135416] | Chr16:21826171..22358401 [GRCh38] Chr16:21837492..22369722 [GRCh37] Chr16:21744993..22277223 [NCBI36] Chr16:16p12.2 |
uncertain significance |
GRCh38/hg38 16p12.2(chr16:21827098-22396630)x1 | copy number loss | See cases [RCV000135984] | Chr16:21827098..22396630 [GRCh38] Chr16:21838419..22407951 [GRCh37] Chr16:21745920..22315452 [NCBI36] Chr16:16p12.2 |
conflicting data from submitters |
GRCh38/hg38 16p12.2(chr16:21717046-22634444)x3 | copy number gain | See cases [RCV000137742] | Chr16:21717046..22634444 [GRCh38] Chr16:21728367..22645765 [GRCh37] Chr16:21635868..22553266 [NCBI36] Chr16:16p12.2 |
uncertain significance |
GRCh38/hg38 16p12.2(chr16:21826171-22436900)x3 | copy number gain | See cases [RCV000137796] | Chr16:21826171..22436900 [GRCh38] Chr16:21837492..22448221 [GRCh37] Chr16:21744993..22355722 [NCBI36] Chr16:16p12.2 |
uncertain significance |
GRCh38/hg38 16p12.2(chr16:21786451-22547506)x3 | copy number gain | See cases [RCV000138712] | Chr16:21786451..22547506 [GRCh38] Chr16:21797772..22558827 [GRCh37] Chr16:21705273..22466328 [NCBI36] Chr16:16p12.2 |
uncertain significance |
GRCh38/hg38 16p12.2(chr16:21790568-22699293)x1 | copy number loss | See cases [RCV000139921] | Chr16:21790568..22699293 [GRCh38] Chr16:21801889..22710614 [GRCh37] Chr16:21709390..22618115 [NCBI36] Chr16:16p12.2 |
uncertain significance |
GRCh38/hg38 16p12.2-11.2(chr16:21350622-29202837)x3 | copy number gain | See cases [RCV000140235] | Chr16:21350622..29202837 [GRCh38] Chr16:21361943..29214158 [GRCh37] Chr16:21269444..29121659 [NCBI36] Chr16:16p12.2-11.2 |
likely pathogenic |
GRCh38/hg38 16p12.2(chr16:21940058-22436900)x1 | copy number loss | See cases [RCV000140693] | Chr16:21940058..22436900 [GRCh38] Chr16:21951379..22448221 [GRCh37] Chr16:21858880..22355722 [NCBI36] Chr16:16p12.2 |
conflicting data from submitters |
GRCh38/hg38 16p12.2(chr16:21750083-22420036)x1 | copy number loss | See cases [RCV000141959] | Chr16:21750083..22420036 [GRCh38] Chr16:21761404..22431357 [GRCh37] Chr16:21668905..22338858 [NCBI36] Chr16:16p12.2 |
uncertain significance |
GRCh38/hg38 16p12.2(chr16:21919927-22430686)x1 | copy number loss | See cases [RCV000141860] | Chr16:21919927..22430686 [GRCh38] Chr16:21931248..22442007 [GRCh37] Chr16:21838749..22349508 [NCBI36] Chr16:16p12.2 |
uncertain significance |
GRCh38/hg38 16p12.2(chr16:21750083-22430686)x1 | copy number loss | See cases [RCV000142326] | Chr16:21750083..22430686 [GRCh38] Chr16:21761404..22442007 [GRCh37] Chr16:21668905..22349508 [NCBI36] Chr16:16p12.2 |
uncertain significance |
GRCh38/hg38 16p12.2(chr16:21790568-22420036)x1 | copy number loss | See cases [RCV000142076] | Chr16:21790568..22420036 [GRCh38] Chr16:21801889..22431357 [GRCh37] Chr16:21709390..22338858 [NCBI36] Chr16:16p12.2 |
uncertain significance |
GRCh38/hg38 16p12.2(chr16:21790568-22430686)x1 | copy number loss | See cases [RCV000143407] | Chr16:21790568..22430686 [GRCh38] Chr16:21801889..22442007 [GRCh37] Chr16:21709390..22349508 [NCBI36] Chr16:16p12.2 |
uncertain significance |
GRCh38/hg38 16p12.2(chr16:21935201-22430686)x1 | copy number loss | See cases [RCV000143283] | Chr16:21935201..22430686 [GRCh38] Chr16:21946522..22442007 [GRCh37] Chr16:21854023..22349508 [NCBI36] Chr16:16p12.2 |
uncertain significance |
GRCh38/hg38 16p12.2(chr16:21919927-22420036)x1 | copy number loss | See cases [RCV000143465] | Chr16:21919927..22420036 [GRCh38] Chr16:21931248..22431357 [GRCh37] Chr16:21838749..22338858 [NCBI36] Chr16:16p12.2 |
uncertain significance |
GRCh38/hg38 16p12.2(chr16:21826171-22396610)x1 | copy number loss | See cases [RCV000148150] | Chr16:21826171..22396610 [GRCh38] Chr16:21837492..22407931 [GRCh37] Chr16:21744993..22315432 [NCBI36] Chr16:16p12.2 |
uncertain significance |
GRCh38/hg38 16p12.2(chr16:21825971-22396751)x1 | copy number loss | See cases [RCV000148152] | Chr16:21825971..22396751 [GRCh38] Chr16:21837292..22408072 [GRCh37] Chr16:21744793..22315573 [NCBI36] Chr16:16p12.2 |
uncertain significance |
GRCh38/hg38 16p12.2(chr16:21826171-22396610)x3 | copy number gain | See cases [RCV000148139] | Chr16:21826171..22396610 [GRCh38] Chr16:21837492..22407931 [GRCh37] Chr16:21744993..22315432 [NCBI36] Chr16:16p12.2 |
uncertain significance |
GRCh37/hg19 16p12.2(chr16:21968752-22407931)x1 | copy number loss | See cases [RCV000240111] | Chr16:21968752..22407931 [GRCh37] Chr16:16p12.2 |
uncertain significance |
GRCh37/hg19 16p13.3-11.2(chr16:102839-28327676)x3 | copy number gain | See cases [RCV000203445] | Chr16:102839..28327676 [GRCh37] Chr16:16p13.3-11.2 |
pathogenic |
GRCh37/hg19 16p12.3-11.2(chr16:19590412-29814175)x3 | copy number gain | Ductal breast carcinoma [RCV000207226] | Chr16:19590412..29814175 [GRCh37] Chr16:16p12.3-11.2 |
uncertain significance |
GRCh37/hg19 16p13.3-11.2(chr16:1279324-31926800)x3 | copy number gain | Ductal breast carcinoma [RCV000207053] | Chr16:1279324..31926800 [GRCh37] Chr16:16p13.3-11.2 |
uncertain significance |
GRCh37/hg19 16p12.2(chr16:21771016-22409463)x1 | copy number loss | See cases [RCV000207445] | Chr16:21771016..22409463 [GRCh37] Chr16:16p12.2 |
pathogenic |
GRCh37/hg19 16p12.2(chr16:21976691-22407931)x1 | copy number loss | See cases [RCV000240052] | Chr16:21976691..22407931 [GRCh37] Chr16:16p12.2 |
uncertain significance |
GRCh37/hg19 16p12.2(chr16:21806299-22407931)x1 | copy number loss | See cases [RCV000239891] | Chr16:21806299..22407931 [GRCh37] Chr16:16p12.2 |
uncertain significance |
GRCh37/hg19 16p12.2(chr16:21968752-22407931)x3 | copy number gain | See cases [RCV000240025] | Chr16:21968752..22407931 [GRCh37] Chr16:16p12.2 |
uncertain significance |
GRCh37/hg19 16p12.2(chr16:21817619-22407931)x1 | copy number loss | See cases [RCV000240390] | Chr16:21817619..22407931 [GRCh37] Chr16:16p12.2 |
uncertain significance |
GRCh37/hg19 16p12.3-11.2(chr16:19424115-30142220)x3 | copy number gain | See cases [RCV000449403] | Chr16:19424115..30142220 [GRCh37] Chr16:16p12.3-11.2 |
pathogenic |
GRCh37/hg19 16p12.2(chr16:21761404-22431357)x1 | copy number loss | See cases [RCV000449301] | Chr16:21761404..22431357 [GRCh37] Chr16:16p12.2 |
pathogenic |
GRCh37/hg19 16p13.3-q24.3(chr16:69193-90274381)x3 | copy number gain | See cases [RCV000446684] | Chr16:69193..90274381 [GRCh37] Chr16:16p13.3-q24.3 |
pathogenic |
GRCh37/hg19 16p12.2(chr16:21801889-22710614)x1 | copy number loss | See cases [RCV000446260] | Chr16:21801889..22710614 [GRCh37] Chr16:16p12.2 |
pathogenic |
GRCh37/hg19 16p12.2(chr16:21801889-22431357)x1 | copy number loss | See cases [RCV000445861] | Chr16:21801889..22431357 [GRCh37] Chr16:16p12.2 |
pathogenic |
GRCh37/hg19 16p12.2(chr16:21852931-22431357)x3 | copy number gain | See cases [RCV000445767] | Chr16:21852931..22431357 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NC_000016.10:g.(?_21939023)_(22424261_?)del | deletion | Schizophrenia [RCV000416649] | Chr16:21939023..22424261 [GRCh38] Chr16:21950344..22435582 [GRCh37] Chr16:21857845..22343083 [NCBI36] Chr16:16p12.2 |
likely pathogenic |
GRCh37/hg19 16p12.2(chr16:21801889-22431357)x3 | copy number gain | See cases [RCV000448291] | Chr16:21801889..22431357 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NC_000016.10:g.(?_21939023)_(22434144_?)dup | duplication | Schizophrenia [RCV000416817] | Chr16:21939023..22434144 [GRCh38] Chr16:21950344..22445465 [GRCh37] Chr16:21857845..22352966 [NCBI36] Chr16:16p12.2 |
likely pathogenic |
GRCh37/hg19 16p12.2(chr16:21986752-22407872)x1 | copy number loss | See cases [RCV000448074] | Chr16:21986752..22407872 [GRCh37] Chr16:16p12.2 |
pathogenic |
GRCh37/hg19 16p12.2(chr16:21841455-22441367)x3 | copy number gain | See cases [RCV000510489] | Chr16:21841455..22441367 [GRCh37] Chr16:16p12.2 |
uncertain significance |
GRCh37/hg19 16p12.2(chr16:21761405-22431357)x1 | copy number loss | See cases [RCV000510163] | Chr16:21761405..22431357 [GRCh37] Chr16:16p12.2 |
uncertain significance |
GRCh37/hg19 16p13.2-q24.3(chr16:9273328-89548493)x3 | copy number gain | See cases [RCV000511622] | Chr16:9273328..89548493 [GRCh37] Chr16:16p13.2-q24.3 |
uncertain significance |
GRCh37/hg19 16p12.2(chr16:21931248-22431357)x3 | copy number gain | See cases [RCV000511685] | Chr16:21931248..22431357 [GRCh37] Chr16:16p12.2 |
likely benign |
GRCh37/hg19 16p12.2(chr16:21801488-22441367)x3 | copy number gain | See cases [RCV000511821] | Chr16:21801488..22441367 [GRCh37] Chr16:16p12.2 |
likely benign |
GRCh37/hg19 16p12.2(chr16:21801889-22431357)x3 | copy number gain | See cases [RCV000511874] | Chr16:21801889..22431357 [GRCh37] Chr16:16p12.2 |
conflicting data from submitters |
GRCh37/hg19 16p12.2(chr16:21801889-22441367)x3 | copy number gain | See cases [RCV000511089] | Chr16:21801889..22441367 [GRCh37] Chr16:16p12.2 |
likely benign |
GRCh37/hg19 16p12.2-11.2(chr16:21596299-30399167)x1 | copy number loss | See cases [RCV000511271] | Chr16:21596299..30399167 [GRCh37] Chr16:16p12.2-11.2 |
pathogenic |
GRCh37/hg19 16p12.2(chr16:21801890-22442007)x1 | copy number loss | See cases [RCV000510848] | Chr16:21801890..22442007 [GRCh37] Chr16:16p12.2 |
uncertain significance |
maternal UPD(16p) | complex | Hemimegalencephaly [RCV000494707] | Chr16:1280042..33710558 [GRCh37] Chr16:16p13.3-11.2 |
pathogenic |
GRCh37/hg19 16p13.3-q24.3(chr16:85881-90155062)x3 | copy number gain | See cases [RCV000512138] | Chr16:85881..90155062 [GRCh37] Chr16:16p13.3-q24.3 |
pathogenic |
GRCh37/hg19 16p13.3-q24.3(chr16:85881-90155062) | copy number gain | See cases [RCV000511296] | Chr16:85881..90155062 [GRCh37] Chr16:16p13.3-q24.3 |
pathogenic |
GRCh37/hg19 16p13.3-12.2(chr16:85880-22442007)x3 | copy number gain | See cases [RCV000511360] | Chr16:85880..22442007 [GRCh37] Chr16:16p13.3-12.2 |
pathogenic |
GRCh37/hg19 16p12.2(chr16:21787031-22431357)x3 | copy number gain | See cases [RCV000512259] | Chr16:21787031..22431357 [GRCh37] Chr16:16p12.2 |
uncertain significance |
GRCh37/hg19 16p12.3-11.2(chr16:18238275-30177240)x3 | copy number gain | See cases [RCV000512428] | Chr16:18238275..30177240 [GRCh37] Chr16:16p12.3-11.2 |
pathogenic |
GRCh37/hg19 16p12.2-11.2(chr16:21379628-29351826)x3 | copy number gain | See cases [RCV000512478] | Chr16:21379628..29351826 [GRCh37] Chr16:16p12.2-11.2 |
pathogenic |
GRCh37/hg19 16p12.2(chr16:21841455-22431357)x1 | copy number loss | See cases [RCV000512595] | Chr16:21841455..22431357 [GRCh37] Chr16:16p12.2 |
uncertain significance |
Single allele | deletion | not provided [RCV000677933] | Chr16:21957432..22396611 [GRCh38] Chr16:21968752..22407931 [GRCh37] Chr16:16p12.2 |
uncertain significance |
GRCh37/hg19 16p12.2(chr16:21801889-22389376)x3 | copy number gain | not provided [RCV000683787] | Chr16:21801889..22389376 [GRCh37] Chr16:16p12.2 |
uncertain significance |
GRCh37/hg19 16p12.2(chr16:21801889-22431357)x1 | copy number loss | not provided [RCV000683788] | Chr16:21801889..22431357 [GRCh37] Chr16:16p12.2 |
pathogenic |
GRCh37/hg19 16p12.2(chr16:21801889-22431357)x3 | copy number gain | not provided [RCV000683789] | Chr16:21801889..22431357 [GRCh37] Chr16:16p12.2 |
uncertain significance |
GRCh37/hg19 16p12.2-11.2(chr16:21379628-29379768)x1 | copy number loss | not provided [RCV000683786] | Chr16:21379628..29379768 [GRCh37] Chr16:16p12.2-11.2 |
pathogenic |
GRCh37/hg19 16p12.2(chr16:21801889-22442007)x1 | copy number loss | not provided [RCV000683790] | Chr16:21801889..22442007 [GRCh37] Chr16:16p12.2 |
pathogenic |
GRCh37/hg19 16p12.2(chr16:21817921-22710614)x1 | copy number loss | not provided [RCV000683791] | Chr16:21817921..22710614 [GRCh37] Chr16:16p12.2 |
pathogenic |
GRCh37/hg19 16p12.2(chr16:21841455-22710614)x1 | copy number loss | not provided [RCV000683792] | Chr16:21841455..22710614 [GRCh37] Chr16:16p12.2 |
pathogenic |
GRCh37/hg19 16p12.2(chr16:21931247-22710614)x1 | copy number loss | not provided [RCV000683793] | Chr16:21931247..22710614 [GRCh37] Chr16:16p12.2 |
pathogenic |
GRCh37/hg19 16p12.2(chr16:21946044-22431357)x3 | copy number gain | not provided [RCV000683794] | Chr16:21946044..22431357 [GRCh37] Chr16:16p12.2 |
uncertain significance |
GRCh37/hg19 16p12.2(chr16:21948756-22442007)x1 | copy number loss | not provided [RCV000683795] | Chr16:21948756..22442007 [GRCh37] Chr16:16p12.2 |
pathogenic |
GRCh37/hg19 16p13.3-q24.3(chr16:88165-90274695)x3 | copy number gain | not provided [RCV000738918] | Chr16:88165..90274695 [GRCh37] Chr16:16p13.3-q24.3 |
pathogenic |
GRCh37/hg19 16p13.3-q24.3(chr16:61451-90294632)x3 | copy number gain | not provided [RCV000738915] | Chr16:61451..90294632 [GRCh37] Chr16:16p13.3-q24.3 |
pathogenic |
GRCh37/hg19 16p13.3-q24.3(chr16:88165-90163275)x3 | copy number gain | not provided [RCV000738917] | Chr16:88165..90163275 [GRCh37] Chr16:16p13.3-q24.3 |
pathogenic |
Single allele | deletion | Schizophrenia [RCV000754178] | Chr16:21928119..22428075 [GRCh38] Chr16:16p12.2 |
likely pathogenic |
Single allele | duplication | Schizophrenia [RCV000754180] | Chr16:21928119..22435412 [GRCh38] Chr16:16p12.2 |
likely pathogenic |
Single allele | duplication | Autistic disorder of childhood onset [RCV000754179] | Chr16:21928119..22428075 [GRCh38] Chr16:16p12.2 |
likely pathogenic |
GRCh37/hg19 16p12.2(chr16:21949122-22421321)x1 | copy number loss | not provided [RCV000739091] | Chr16:21949122..22421321 [GRCh37] Chr16:16p12.2 |
benign |
GRCh37/hg19 16p12.2(chr16:21949122-22443623)x1 | copy number loss | not provided [RCV000739092] | Chr16:21949122..22443623 [GRCh37] Chr16:16p12.2 |
benign |
GRCh37/hg19 16p12.2(chr16:21949122-22449883)x1 | copy number loss | not provided [RCV000739093] | Chr16:21949122..22449883 [GRCh37] Chr16:16p12.2 |
benign |
GRCh37/hg19 16p12.2(chr16:21951379-22407931)x3 | copy number gain | not provided [RCV000762766] | Chr16:21951379..22407931 [GRCh37] Chr16:16p12.2 |
likely benign |
GRCh37/hg19 16p12.2(chr16:21769324-22435811)x1 | copy number loss | not provided [RCV000751623] | Chr16:21769324..22435811 [GRCh37] Chr16:16p12.2 |
likely pathogenic |
GRCh37/hg19 16p12.2(chr16:21769324-22552780)x1 | copy number loss | not provided [RCV000751624] | Chr16:21769324..22552780 [GRCh37] Chr16:16p12.2 |
likely pathogenic |
GRCh37/hg19 16p12.2(chr16:21973828-22361172) | copy number loss | Chromosome 16p12.1 deletion syndrome, 520-kb [RCV000767762] | Chr16:21973828..22361172 [GRCh37] Chr16:16p12.2 |
likely pathogenic |
GRCh37/hg19 16p12.2(chr16:21976691-22386881) | copy number loss | Chromosome 16p12.1 deletion syndrome, 520-kb [RCV000767607] | Chr16:21976691..22386881 [GRCh37] Chr16:16p12.2 |
pathogenic |
GRCh37/hg19 16p12.2(chr16:21973828-22361172) | copy number loss | Chromosome 16p12.1 deletion syndrome, 520-kb [RCV000767685] | Chr16:21973828..22361172 [GRCh37] Chr16:16p12.2 |
likely pathogenic |
GRCh37/hg19 16p12.2(chr16:21943463-22702769) | copy number loss | Chromosome 16p12.1 deletion syndrome, 520-kb [RCV000767585] | Chr16:21943463..22702769 [GRCh37] Chr16:16p12.2 |
likely pathogenic |
GRCh37/hg19 16p12.2(chr16:21964083-22386845) | copy number loss | Chromosome 16p12.1 deletion syndrome, 520-kb [RCV000767694] | Chr16:21964083..22386845 [GRCh37] Chr16:16p12.2 |
pathogenic |
GRCh37/hg19 16p12.2(chr16:21785197-22431357)x3 | copy number gain | not provided [RCV000846556] | Chr16:21785197..22431357 [GRCh37] Chr16:16p12.2 |
uncertain significance |
GRCh37/hg19 16p12.2(chr16:21841353-22442007)x3 | copy number gain | not provided [RCV000849792] | Chr16:21841353..22442007 [GRCh37] Chr16:16p12.2 |
uncertain significance |
Database | Acc Id | Source(s) |
AGR Gene | HGNC:30347 | AgrOrtholog |
COSMIC | POLR3E | COSMIC |
Ensembl Genes | ENSG00000058600 | ENTREZGENE, UniProtKB/Swiss-Prot |
ENSG00000284282 | UniProtKB/Swiss-Prot | |
Ensembl Protein | ENSP00000299853 | ENTREZGENE, UniProtKB/Swiss-Prot |
ENSP00000352140 | ENTREZGENE, UniProtKB/Swiss-Prot | |
ENSP00000399254 | ENTREZGENE, UniProtKB/Swiss-Prot | |
ENSP00000454225 | UniProtKB/TrEMBL | |
ENSP00000454507 | UniProtKB/TrEMBL | |
ENSP00000454875 | UniProtKB/TrEMBL | |
ENSP00000456454 | UniProtKB/TrEMBL | |
ENSP00000456526 | UniProtKB/TrEMBL | |
ENSP00000456718 | UniProtKB/TrEMBL | |
ENSP00000456771 | UniProtKB/TrEMBL | |
ENSP00000456967 | ENTREZGENE, UniProtKB/Swiss-Prot | |
ENSP00000484648 | ENTREZGENE, UniProtKB/TrEMBL | |
ENSP00000492263 | UniProtKB/Swiss-Prot | |
ENSP00000492534 | UniProtKB/Swiss-Prot | |
ENSP00000492586 | UniProtKB/Swiss-Prot | |
ENSP00000492639 | UniProtKB/Swiss-Prot | |
Ensembl Transcript | ENST00000299853 | ENTREZGENE, UniProtKB/Swiss-Prot |
ENST00000359210 | ENTREZGENE, UniProtKB/Swiss-Prot | |
ENST00000418581 | ENTREZGENE, UniProtKB/Swiss-Prot | |
ENST00000561494 | UniProtKB/TrEMBL | |
ENST00000563024 | UniProtKB/TrEMBL | |
ENST00000564209 | ENTREZGENE, UniProtKB/Swiss-Prot | |
ENST00000564750 | UniProtKB/TrEMBL | |
ENST00000564883 | UniProtKB/TrEMBL | |
ENST00000565358 | UniProtKB/TrEMBL | |
ENST00000565551 | UniProtKB/TrEMBL | |
ENST00000569757 | UniProtKB/TrEMBL | |
ENST00000615879 | ENTREZGENE, UniProtKB/TrEMBL | |
ENST00000638476 | UniProtKB/Swiss-Prot | |
ENST00000638525 | UniProtKB/Swiss-Prot | |
ENST00000639149 | UniProtKB/Swiss-Prot | |
ENST00000640588 | UniProtKB/Swiss-Prot | |
GTEx | ENSG00000058600 | GTEx |
ENSG00000284282 | GTEx | |
HGNC ID | HGNC:30347 | ENTREZGENE |
Human Proteome Map | POLR3E | Human Proteome Map |
InterPro | RNA_pol_III_Rpc5 | UniProtKB/Swiss-Prot |
KEGG Report | hsa:55718 | UniProtKB/Swiss-Prot |
NCBI Gene | 55718 | ENTREZGENE |
OMIM | 617815 | OMIM |
PANTHER | PTHR12069 | UniProtKB/Swiss-Prot |
Pfam | Sin_N | UniProtKB/Swiss-Prot |
PharmGKB | PA134964025 | PharmGKB |
UniGene | Hs.460298 | ENTREZGENE |
UniProt | A0A0C4DH01 | ENTREZGENE, UniProtKB/TrEMBL |
H3BM46_HUMAN | UniProtKB/TrEMBL | |
H3BMR4_HUMAN | UniProtKB/TrEMBL | |
H3BNJ0_HUMAN | UniProtKB/TrEMBL | |
H3BRY1_HUMAN | UniProtKB/TrEMBL | |
H3BS41_HUMAN | UniProtKB/TrEMBL | |
H3BSI5_HUMAN | UniProtKB/TrEMBL | |
H3BSM3_HUMAN | UniProtKB/TrEMBL | |
Q9NVU0 | ENTREZGENE, UniProtKB/Swiss-Prot | |
UniProt Secondary | B4DL24 | UniProtKB/Swiss-Prot |
B4DUP6 | UniProtKB/Swiss-Prot | |
H3BT11 | UniProtKB/Swiss-Prot | |
Q9BWF7 | UniProtKB/Swiss-Prot | |
Q9H8W8 | UniProtKB/Swiss-Prot | |
Q9H907 | UniProtKB/Swiss-Prot | |
Q9P276 | UniProtKB/Swiss-Prot |
Date | Current Symbol | Current Name | Previous Symbol | Previous Name | Description | Reference | Status |
---|---|---|---|---|---|---|---|
2016-07-19 | POLR3E | RNA polymerase III subunit E | polymerase (RNA) III subunit E | Symbol and/or name change | 5135510 | APPROVED | |
2016-03-07 | POLR3E | polymerase (RNA) III subunit E | polymerase (RNA) III (DNA directed) polypeptide E (80kD) | Symbol and/or name change | 5135510 | APPROVED |
![]() |
More on POLR3E | |
![]() |
Alliance Gene |
![]() |
NCBI Gene |
![]() |
Ensembl Gene |
![]() |
JBrowse: hg19 hg38 |
![]() |
HGNC Report |
![]() |
NCBI Genome Data Viewer |
CRRD Object Information | |
CRRD ID: | 1317654 |
Created: | 2005-01-12 |
Species: | Homo sapiens |
Last Modified: | 2019-11-26 |
Status: | ACTIVE |
![]() |
![]() |
![]() |
![]() |
RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.